Drug
Cytarabine
Cytarabine: highest development phase Phase 2, developed by Jazz Pharmaceuticals, Roche. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jazz Pharmaceuticals, Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cytarabine NCT02419469 | Phase 2 | Leukemia |
| cytarabine NCT01880437 | Phase 2 | Myelodysplastic Syndromes, Myelogenous Leukemia, Acute |
Latest
No recent events.
Follow Cytarabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.